RSS
fexinidazole
EMA review of sleeping sickness treatment requested by Sanofi
Sanofi has requested a review by the European Medicines Agency (EMA) of its treatment for sleeping sickness, fexinidazole, which it is developing in collaboration with the Drugs for Neglected Disease initiative (DNDi). Read more